Inotek Pharma (ITEK) Announces $20.97M Conv. Senior Notes Conversion to Common Stock
Tweet Send to a Friend
Inotek Pharma (NASDAQ: ITEK) announced that $20,970,000 of its 5.0% Convertible Senior Notes due 2020 (the “2020 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE